AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
IPO Year: 2018
Exchange: NASDAQ
Website: adapthealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/8/2024 | $14.50 → $8.00 | Buy → Hold | Jefferies |
| 11/8/2023 | $9.50 → $6.50 | Neutral → Underperform | BofA Securities |
| 5/10/2023 | $28.00 → $11.30 | Buy → Hold | Deutsche Bank |
| 5/10/2023 | $18.00 → $11.00 | Buy → Hold | Stifel |
| 5/9/2023 | $21.00 → $12.00 | Buy → Neutral | BofA Securities |
| 3/8/2022 | $31.00 → $26.00 | Outperform | RBC Capital |
| 3/2/2022 | $32.00 → $24.00 | Outperform | SVB Leerink |
| 2/18/2022 | $35.00 → $32.00 | Outperform | SVB Leerink |
| 11/5/2021 | $30.00 → $35.00 | Outperform | SVB Leerink |
| 9/27/2021 | $30.00 | Outperform | SVB Leerink |
8-K - AdaptHealth Corp. (0001725255) (Filer)
8-K - AdaptHealth Corp. (0001725255) (Filer)
8-K - AdaptHealth Corp. (0001725255) (Filer)
144 - AdaptHealth Corp. (0001725255) (Subject)
144 - AdaptHealth Corp. (0001725255) (Subject)
8-K - AdaptHealth Corp. (0001725255) (Filer)
144 - AdaptHealth Corp. (0001725255) (Subject)
144 - AdaptHealth Corp. (0001725255) (Subject)
144 - AdaptHealth Corp. (0001725255) (Subject)
8-K - AdaptHealth Corp. (0001725255) (Filer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
3 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
3 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced the appointment of Diana Nole to the Board of Directors, effective October 16, 2024. "We are thrilled to welcome Diana to the AdaptHealth Board of Directors. Her extensive leadership experience in the healthcare technology sector caught our eye and we soon discovered that her decisive, resourceful leadership style and expertise in business transformation aligned perfectly with our current goals as an organization," said Dale Wolf, Chairman of the AdaptHealth B
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its third quarter 2024 financial results before the opening of the financial markets on Tuesday, November 5, 2024. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-4136 (Domestic) or (203) 518-9843 (International) When prompted, reference Conference ID: AHCO3Q24 Webcast registration: Click Here Following the
Advantage Healthcare Holdings ("Advantage" or the "Company"), a regional leader in providing patient-centered healthcare through managing and operating Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers, announced that its Board of Directors has named Dinak (Dino) Nair as its Chief Executive Officer. Mr. Nair assumed leadership of the Company from the prior CEO, Ryan Tong, on September 1, 2024. Mr. Nair brings over 20 years of business experience, with more than a decade as a mission-driven leader growing businesses in the healthcare market, especially in homecare, home medical equipment, diagnostic laboratory, and health system partnerships. Mr. Nair most recently served
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that it has closed a $950 million senior secured credit facility, consisting of a fully funded $650 million Term Loan A (the "Term Loan"), and a $300 million revolving line of credit (the "Revolver"). Proceeds from the new $650 million Term Loan were used to fully repay, without penalty, the Company's existing Term Loan due to reach final maturity in January 2026. The new $300 million Revolver replaces the Company's existing $450 million revolving credit faci
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the Baird Global Healthcare Conference, being held in New York, on Tuesday, September 10, 2024, including a fireside chat at 12:15pm ET. About AdaptHealth Corp. AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full suite of medical products and solutions designed to help patients man
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Scott Barnhart has been appointed as Chief Operating Officer, effective September 23, 2024. Mr. Barnhart has more than 30 years of leadership experience in global operations including supply chain management, manufacturing, procurement, logistics, customer service and product portfolio management. Most recently, he served as Chief Operating Officer of Qurate Retail Group, a leading global retail group, where he led operational and productivity improvemen
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the Canaccord Genuity 44th Annual Growth Conference, being held in Boston, on Wednesday, August 14, 2024, including a fireside chat presentation at 1:30 pm ET. The webcast link will be available on the Company's website, www.adapthealth.com under "Investor Relations." About AdaptHealth Corp. AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medic
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2024 financial results before the opening of the financial markets on Tuesday, August 6, 2024. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-4136 (Domestic) or (203) 518-9843 (International) When prompted, reference Conference ID: AHCO2Q24 Webcast registration: Click Here Followin
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today the appointment of Dale Wolf as Chair of the Board of Directors, effective July 1, 2024. Mr. Wolf has served on AdaptHealth's Board since November 2019 and will assume the role from outgoing Chairman Richard Barasch. Additionally, Suzanne Foster, AdaptHealth's Chief Executive Officer, has joined the Board of Directors, effective May 20, 2024. "I am thrilled to assume the role and look forward to working alongside Suzanne and her team to leverage the momentum
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the Goldman Sachs 45th Annual Global Healthcare Conference, being held in Miami, on Wednesday, June 12, 2024, including a presentation at 9:20am ET. About AdaptHealth Corp. AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full suite of medical products and solutions designed to help
SC 13D/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13D/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13D/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13D/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its third quarter 2024 financial results before the opening of the financial markets on Tuesday, November 5, 2024. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-4136 (Domestic) or (203) 518-9843 (International) When prompted, reference Conference ID: AHCO3Q24 Webcast registration: Click Here Following the
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2024 financial results before the opening of the financial markets on Tuesday, August 6, 2024. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-4136 (Domestic) or (203) 518-9843 (International) When prompted, reference Conference ID: AHCO2Q24 Webcast registration: Click Here Followin
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2024 financial results before the opening of the financial markets on Tuesday, May 7, 2024. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 579-2543 (Domestic) or (785) 424-1789 (International) When prompted, reference Conference ID: AHCO1Q24 Webcast registration: Click Here Following th
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its fourth quarter and full year 2023 financial results before the opening of the financial markets on Tuesday, February 27, 2024. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 245-3047 (Domestic) or (203) 518-9765 (International) When prompted, reference Conference ID: AHCO4Q23 Webcast registration: Clic
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the third quarter ended September 30, 2023. Third Quarter Results and Highlights All comparisons are to the quarter ended September 30, 2022 unless otherwise stated. Net revenue was $804.0 million compared to $756.5 million, an increase of 6.3%. Net loss attributable to AdaptHealth Corp. was $454.1 million compared to net income of $16.1 million, largely resulting from a $511.9 million pre-tax write down of goodwill. Adjuste
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its third quarter 2023 financial results before the opening of the financial markets on Tuesday, November 7, 2023. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 245-3047 (Domestic) or (203) 518-9765 (International) When prompted, reference Conference ID: AHCO3Q23 Webcast registration: Click Here Followi
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2023. Second Quarter Results and Highlights All comparisons are to the quarter ended June 30, 2022 unless otherwise stated. Net revenue was $793.3 million compared to $727.6 million, an increase of 9.0%. Non-acquired net revenue growth was 8.7%. Net income attributable to AdaptHealth Corp. was $14.0 million, compared to $14.0 million. Adjusted EBITDA was $171.0 million, compared to $150.0
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2023 financial results before the opening of the financial markets on Tuesday, August 8, 2023. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 245-3047 (Domestic) or (203) 518-9765 (International) When prompted, reference Conference ID: AHCO2Q23 Webcast registration: Click Here Followin
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2023. First Quarter Results and Highlights Net revenue was $744.6 million compared to $706.2 million in the first quarter of 2022, an increase of 5.4%, including 17.6% growth in our Sleep categories. Non-acquired growth was 4.7%. Net income attributable to AdaptHealth Corp. was $15.7 million. Adjusted EBITDA was $134.0 million, compared to $137.6 million in the first quarter of 2022, a dec
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2023 financial results before the opening of the financial markets on Tuesday, May 9, 2023. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 245-3047 (Domestic) or (203) 518-9765 (International) When prompted, reference Conference ID: AHCO1Q23 Webcast registration: Click Here Following th
Jefferies downgraded AdaptHealth from Buy to Hold and set a new price target of $8.00 from $14.50 previously
BofA Securities downgraded AdaptHealth from Neutral to Underperform and set a new price target of $6.50 from $9.50 previously
Deutsche Bank downgraded AdaptHealth from Buy to Hold and set a new price target of $11.30 from $28.00 previously
Stifel downgraded AdaptHealth from Buy to Hold and set a new price target of $11.00 from $18.00 previously
BofA Securities downgraded AdaptHealth from Buy to Neutral and set a new price target of $12.00 from $21.00 previously
RBC Capital reiterated coverage of AdaptHealth with a rating of Outperform and set a new price target of $26.00 from $31.00 previously
SVB Leerink reiterated coverage of AdaptHealth with a rating of Outperform and set a new price target of $24.00 from $32.00 previously
SVB Leerink reiterated coverage of AdaptHealth with a rating of Outperform and set a new price target of $32.00 from $35.00 previously
SVB Leerink reiterated coverage of AdaptHealth with a rating of Outperform and set a new price target of $35.00 from $30.00 previously
SVB Leerink initiated coverage of AdaptHealth with a rating of Outperform and set a new price target of $30.00
Wolf has served on AdaptHealth's Board since November 2019 and will assume the role from outgoing Chairman Richard Barasch. Additionally, Suzanne Foster, AdaptHealth's Chief Executive Officer, has joined the Board of Directors, effective May 20, 2024. The Company also announced today that Josh Parnes, AdaptHealth's President and a member of the Board of Directors, will be stepping down from his role as President effective August 31, 2024 and from the Board effective December 31, 2024.
AdaptHealth (NASDAQ:AHCO) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 1 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 2 1 0 0 0 Analysts have recently evaluated AdaptHealth and provided 12-month price targets. The average target is $13.0, accompanied by a high estimate of $13.00
Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and maintains $13 price target.
AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.05 by 140 percent. The company reported quarterly sales of $792.497 million which beat the analyst consensus estimate of $769.867 million by 2.94 percent. This is a 6.43 percent increase over sales of $744.626 million the same period last year.
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Suzanne Foster as its Chief Executive Officer. Ms. Foster will assume leadership of the Company from interim CEO and Chairman of the Board, Richard Barasch, on May 20, 2024.Ms. Foster will join the Company from Danaher Corporation where she served as President of Beckman Coulter Life Sciences, a global provider of biomedical technologies and laboratory instruments. Ms. Foster brings over 25 years of healthcare experience as
Ratings for AdaptHealth (NASDAQ:AHCO) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 1 0 0 0 Last 30D 0 1 0 0 0 1M Ago 2 0 0 0 0 2M Ago 1 0 0 0 0 3M Ago 0 0 0 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $12.0, a high estimate of $13.00, and a low estimate of $9.00. This current average has increased
RBC Capital analyst Ben Hendrix reiterates AdaptHealth (NASDAQ:AHCO) with a Outperform and maintains $13 price target.
UBS analyst Whit Mayo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $9 to $13.
Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $11 to $13.
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday. Shares of Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) rose sharply during Tuesday’s session following better-than-expected fourth-quarter revenues. Norwegian Cruise Line posted adjusted loss of 18 cents per share on revenue of $1.99 billion, according to data from Benzinga Pro. Norwegian Cruise Line shares jumped 13% to $18.00 on Tuesday. Here are some other big stocks recording gains in today’s session. Janux Therapeutics, Inc. (NASDAQ:JANX) shares rose 145% to $37.00 after the company announced updated clinical data for both of its clinical programs. Viking Therapeutics, Inc. (NASDAQ:VKTX)
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced the appointment of Diana Nole to the Board of Directors, effective October 16, 2024. "We are thrilled to welcome Diana to the AdaptHealth Board of Directors. Her extensive leadership experience in the healthcare technology sector caught our eye and we soon discovered that her decisive, resourceful leadership style and expertise in business transformation aligned perfectly with our current goals as an organization," said Dale Wolf, Chairman of the AdaptHealth B
Advantage Healthcare Holdings ("Advantage" or the "Company"), a regional leader in providing patient-centered healthcare through managing and operating Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers, announced that its Board of Directors has named Dinak (Dino) Nair as its Chief Executive Officer. Mr. Nair assumed leadership of the Company from the prior CEO, Ryan Tong, on September 1, 2024. Mr. Nair brings over 20 years of business experience, with more than a decade as a mission-driven leader growing businesses in the healthcare market, especially in homecare, home medical equipment, diagnostic laboratory, and health system partnerships. Mr. Nair most recently served
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today the appointment of Dale Wolf as Chair of the Board of Directors, effective July 1, 2024. Mr. Wolf has served on AdaptHealth's Board since November 2019 and will assume the role from outgoing Chairman Richard Barasch. Additionally, Suzanne Foster, AdaptHealth's Chief Executive Officer, has joined the Board of Directors, effective May 20, 2024. "I am thrilled to assume the role and look forward to working alongside Suzanne and her team to leverage the momentum
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Suzanne Foster as its Chief Executive Officer. Ms. Foster will assume leadership of the Company from interim CEO and Chairman of the Board, Richard Barasch, on May 20, 2024. Ms. Foster will join the Company from Danaher Corporation where she served as President of Beckman Coulter Life Sciences, a global provider of biomedical technologies and laboratory instruments. Ms. Foster brings over 25 years of healthcare experience
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies and related services, announced today that its Board of Directors has named Crispin Teufel as Chief Executive Officer. Teufel is expected to assume the role on September 1, 2023. Crispin Teufel, 47, has served as the Chief Executive Officer of Lincare Holdings Inc., a leading national provider of in-home respiratory care with over 700 locations in 48 states, since July 2017. Previously, Mr. Teufel served as the Chief Financial Officer of Lincare from 2013 to 2019 and as a Finance Director for Lin
Board Has Initiated a Search for a Successor AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies and related services, announced today that Stephen Griggs will step down as Chief Executive Officer by mutual agreement with the Board of Directors, effective June 30, 2023. The Board is working with a leading executive search firm to identify a new CEO and is considering several qualified candidates. Richard Barasch, Chairman of the Board, will serve as interim CEO if a successor to Mr. Griggs is not appointed by the time of his departure. Mr. Grigg
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Greg Belinfanti was appointed to the Company's Board of Directors. Mr. Belinfanti is a Senior Managing Director of One Equity Partners and will serve as OEP's designee on the Board of Directors. Mr. Belinfanti currently sits on the boards of Restorix Health and Ernest Health, and was also formerly a board member of Simplura Health Group, Arthrocare Inc (NASDAQ:ARTC), and Celltrion Healthcare, a publicly listed company in Korea. Brad Coppens, previously app
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today the appointment of Anton Hie as Vice President, Investor Relations, a newly created position. Mr. Hie will report to Jason Clemens, AdaptHealth's Chief Financial Officer. As Vice President, Investor Relations, Mr. Hie will collaborate with AdaptHealth's senior management team on the Company's growth and competitive strategy. He will also have primary responsibility for managing AdaptHealth's communications with its public shareholders and the investment commun
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company") announced today that its Board of Directors (the "Board") has appointed Stephen Griggs as Chief Executive Officer of the Company, effective immediately. Mr. Griggs, who is also a member of the Board, joined AdaptHealth in February 2021 as Co-CEO following the Company's acquisition of AeroCare Holdings, Inc., which Mr. Griggs founded and led as President and CEO. The Company also announced that Luke McGee has resigned from his positions as Co-CEO of AdaptHealth and a member of the Board. A Special Committee of independent directors, established by the Board to oversee a thorough investigation of any connection between Mr. McG